Article | September 3, 2020

A New Aseptic Solution For The Filling Of Complex Parenterals In Powder, Liquid Or Suspension Form

Source: Evonik Corporation
Evonik Pharma Image 2

Traditional filling lines lack the necessary versatility to address the growing number of complex and personalized parenteral drug products that are now being brought to market. Evonik has recently qualified a new modular aseptic filling platform that will efficiently fill drug products in powder, liquid, suspension or combination form.

Many parenteral products that utilize advanced formulation technologies to deliver complex small molecules, peptides, proteins, and nucleic acids can face a number of stability, sterility, scalability and other cGMP manufacturing challenges. As one example, while terminal sterilization methods such as gamma irradiation are highly effective and reliable, this process may degrade the active pharmaceutical ingredient. This inherent incompatibility has necessitated the creation of specialized solutions for the aseptic manufacturing and filling of these parenteral drug products. 

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online